HIV Status Does Not Appear To Affect Outcomes Of Tecovirimat Treatment For Patients With Mpox, Study Suggests

Infectious Disease Advisor (5/2, Media) reports, “HIV status seems not to affect treatment outcomes among patients receiving tecovirimat for mpox, according to a study.” The findings were published in the Annals of Internal Medicine.